Chardan Capital Maintains Buy on Coya Therapeutics, Maintains $14 Price Target
County Bk Greenwood S C Com +16.44%
County Bk Greenwood S C Com COYA | 9.63 | +16.44% |
Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:
COYA) with a Buy and maintains $14 price target.